492(top 1%)
papers
17.7K(top 1%)
citations
65(top 1%)
h-index
111(top 1%)
g-index
531
all documents
19.8K
doc citations
3.0K
citing journals

Top Articles

#TitleJournalYearCitations
1Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal CancerJAMA - Journal of the American Medical Association2017891
2Bladder cancerNature Reviews Disease Primers2017590
3Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS StudiesClinical Cancer Research2014561
4Association Between Telomere Length and Risk of Cancer and Non-Neoplastic DiseasesJAMA Oncology2017376
5Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016European Journal of Cancer2016330
6POT1 loss-of-function variants predispose to familial melanomaNature Genetics2014319
7Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robustJournal of Clinical Epidemiology2016306
8Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeScience Translational Medicine2018288
9New loci for body fat percentage reveal link between adiposity and cardiometabolic disease riskNature Communications2016245
10The ERK and JNK pathways in the regulation of metabolic reprogrammingOncogene2019244
11Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging–Only Radiation TherapyInternational Journal of Radiation Oncology Biology Physics2018235
12World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal CancerGastroenterology2018221
13Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanomaNature Genetics2015218
14ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsBlood2016214
15A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL studyLeukemia2016200
16Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomasGut2015197
17Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysisNature Communications2020193
18The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgeryInternational Journal of Colorectal Disease2014186
19HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsJournal of Pathology2016185
20International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumLancet Oncology, The2020180
21Host Inflammatory Response to Mosquito Bites Enhances the Severity of Arbovirus InfectionImmunity2016178
22Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+T cell traffickingProceedings of the National Academy of Sciences of the United States of America2018165
23Variation in genomic landscape of clear cell renal cell carcinoma across EuropeNature Communications2014158
24Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsLancet Oncology, The2016158
25FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre studyBritish Journal of Cancer2014154
26mTOR Regulation of Glycolytic Metabolism in T CellsFrontiers in Cell and Developmental Biology2018142
27Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsAnnals of Oncology2017132
28In vivomodels in breast cancer research: progress, challenges and future directionsDMM Disease Models and Mechanisms2017131
29Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessNature Communications2016127
30Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer RiskAmerican Journal of Human Genetics2020124
31Rare disruptive mutations and their contribution to the heritable risk of colorectal cancerNature Communications2016122
32Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic ReviewJournal of Medical Internet Research2019121
33Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset CancerGastroenterology2020110
34Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expressionAnnals of the Rheumatic Diseases2019109
35High hospital research participation and improved colorectal cancer survival outcomes: a population-based studyGut2017107
36Minimal residual disease is an independent predictor for 10-year survival in CLLBlood2016106
37Genome-wide association study identifies multiple risk loci for renal cell carcinomaNature Communications2017106
38Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumorNature Genetics2017105
39Germline MC1R status influences somatic mutation burden in melanomaNature Communications2016103
40RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem CellsStem Cell Reports2017100
41Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumourBritish Journal of Cancer201599
42Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignanciesLancet Haematology,the201897
43Blimp‐1 homolog Hobit identifies effector‐type lymphocytes in humansEuropean Journal of Immunology201594
44Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?British Journal of Cancer201892
45The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancerBritish Journal of Cancer201490
46The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumoniaProceedings of the National Academy of Sciences of the United States of America202089
47Patient-reported outcomes in cancer survivors: a population-wide cross-sectional studySupportive Care in Cancer201787
48Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility studyBMJ Open201787
49Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysNature Communications201887
50Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profilingBMC Medical Genomics201584